MLchartDataset catalogue

Nadroparin calcium

Term · Oncology and biomedicine · MLC-T-ONC-015408

A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt. Nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot.

Table 1. Record
IdentifierMLC-T-ONC-015408
FieldOncology and biomedicine
Synonymsnadroparin
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015408",
  "term": "Nadroparin calcium",
  "field": "Oncology and biomedicine",
  "definition": "A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerisation of porcine mucosal sodium heparin, extraction/purification and conversion to the calcium salt. Nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot.",
  "synonyms": [
    "nadroparin"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/nadroparin-calcium/"
}

Record 11,550 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.